Catalent opens clinical trial supply facility in Shanghai, China

Will provide an end-to-end service from supply management to storage and distribution

Scott Houlton, President of Development Services at Catalent (left) and Dave Heyens, President Catalent Asia Pacific, celebrate the opening of the new facility in Shanghai

Catalent Pharma Solutions, a drug deliver specialist has completed construction and validation of its 31,000ft2 clinical supply facility in Shanghai, China. Catalent business leaders, local employees, customers and partners celebrated at a site opening ceremony, less than nine months after construction began on the site.

The Somerset, NJ, US firm says it is the first clinical supply facility in China to provide an end-to-end service from clinical supply management, comparator sourcing and primary packaging to storage and distribution. The facility is also validated to support biologics requiring refrigerated and frozen supply chain management. Catalent has already secured customer projects for the site, which is now undergoing customer validation for the supply of clinical trial materials.

The Catalent (Shanghai) Clinical Trial Supplies facility is the eighth in the firm’s global clinical supply network and is located in Shanghai’s Waigaoqiao Free Trade Zone.

'China is a fast growing market for the pharmaceutical industry and a market that Catalent will continue to invest in,' said Scott Houlton, President of Development and Clinical Services at Catalent. 'Having started work on our China clinical supply strategy two years ago, I’m excited to see this strategy implemented and the new site open for business. It is a great addition to Catalent’s global clinical supply network and will help to better serve our customers increasing need for clinical trials in Asia.'

Featured Companies

Catalent (more information, website)